Report Detail
Global Ischemia Reperfusion Injury Market Size, Status and Forecast 2019-2025
- RnM3283057 |
- 08 April, 2019 |
- Global |
- 102 Pages |
- QYResearch |
- Other
Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.
Ischemic reperfusion injury is the tissue damage that happens when blood supply returns to the tissue after a period of lack of oxygen. The absence of oxygen and nutrients creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative. Symptoms include headache, bradycardia, seizures and hypertension. Risk factors include hypertension, hyperlipidemia, diabetes, insulin resistance, heart failure, altered coronary circulation, and aging.
Ischemia Reperfusion Injury can be applied in Heart Injury, Kidney Injury, Intestine Injury and Other. The most of Ischemia Reperfusion Injury is used in Kidney Injury, and the market share of that is about 66% in 2035.
North America is the largest sales place, with a sales market share nearly 54% in 2035. Following North America, Europe is the second largest sales place with the Sales market share of 14.5%. Ischemia Reperfusion Injury market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India.
In 2018, the global Ischemia Reperfusion Injury market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Ischemia Reperfusion Injury status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ischemia Reperfusion Injury development in United States, Europe and China.
The key players covered in this study
Angion Biomedica
Catalyst Biosciences
Ischemix Inc
Opsona Therapeutics
Pharming
TheraSource
Bolder Biotechnology
Corline Biomedical
Mifcortx
Balmes Transplantation
NovelMed Therapeutics
Hope Pharmaceuticals
Omeros Corp
Prothix
SBI Pharmaceuticals
Market segment by Type, the product can be split into
Phase 1
Phase 2
Preclinical
Market segment by Application, split into
Heart Injury
Kidney Injury
Intestine Injury
Other Injury
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Ischemia Reperfusion Injury status, future forecast, growth opportunity, key market and key players.
To present the Ischemia Reperfusion Injury development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Ischemia Reperfusion Injury are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Ischemia Reperfusion Injury Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Phase 1
- 1.4.3 Phase 2
- 1.4.4 Preclinical
- 1.5 Market by Application
- 1.5.1 Global Ischemia Reperfusion Injury Market Share by Application (2014-2025)
- 1.5.2 Heart Injury
- 1.5.3 Kidney Injury
- 1.5.4 Intestine Injury
- 1.5.5 Other Injury
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Ischemia Reperfusion Injury Market Size
- 2.2 Ischemia Reperfusion Injury Growth Trends by Regions
- 2.2.1 Ischemia Reperfusion Injury Market Size by Regions (2014-2025)
- 2.2.2 Ischemia Reperfusion Injury Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Ischemia Reperfusion Injury Market Size by Manufacturers
- 3.1.1 Global Ischemia Reperfusion Injury Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Ischemia Reperfusion Injury Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Ischemia Reperfusion Injury Market Concentration Ratio (CR5 and HHI)
- 3.2 Ischemia Reperfusion Injury Key Players Head office and Area Served
- 3.3 Key Players Ischemia Reperfusion Injury Product/Solution/Service
- 3.4 Date of Enter into Ischemia Reperfusion Injury Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Ischemia Reperfusion Injury Market Size by Type (2014-2019)
- 4.2 Global Ischemia Reperfusion Injury Market Size by Application (2014-2019)
5 United States
- 5.1 United States Ischemia Reperfusion Injury Market Size (2014-2019)
- 5.2 Ischemia Reperfusion Injury Key Players in United States
- 5.3 United States Ischemia Reperfusion Injury Market Size by Type
- 5.4 United States Ischemia Reperfusion Injury Market Size by Application
6 Europe
- 6.1 Europe Ischemia Reperfusion Injury Market Size (2014-2019)
- 6.2 Ischemia Reperfusion Injury Key Players in Europe
- 6.3 Europe Ischemia Reperfusion Injury Market Size by Type
- 6.4 Europe Ischemia Reperfusion Injury Market Size by Application
7 China
- 7.1 China Ischemia Reperfusion Injury Market Size (2014-2019)
- 7.2 Ischemia Reperfusion Injury Key Players in China
- 7.3 China Ischemia Reperfusion Injury Market Size by Type
- 7.4 China Ischemia Reperfusion Injury Market Size by Application
8 Japan
- 8.1 Japan Ischemia Reperfusion Injury Market Size (2014-2019)
- 8.2 Ischemia Reperfusion Injury Key Players in Japan
- 8.3 Japan Ischemia Reperfusion Injury Market Size by Type
- 8.4 Japan Ischemia Reperfusion Injury Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Ischemia Reperfusion Injury Market Size (2014-2019)
- 9.2 Ischemia Reperfusion Injury Key Players in Southeast Asia
- 9.3 Southeast Asia Ischemia Reperfusion Injury Market Size by Type
- 9.4 Southeast Asia Ischemia Reperfusion Injury Market Size by Application
10 India
- 10.1 India Ischemia Reperfusion Injury Market Size (2014-2019)
- 10.2 Ischemia Reperfusion Injury Key Players in India
- 10.3 India Ischemia Reperfusion Injury Market Size by Type
- 10.4 India Ischemia Reperfusion Injury Market Size by Application
11 Central & South America
- 11.1 Central & South America Ischemia Reperfusion Injury Market Size (2014-2019)
- 11.2 Ischemia Reperfusion Injury Key Players in Central & South America
- 11.3 Central & South America Ischemia Reperfusion Injury Market Size by Type
- 11.4 Central & South America Ischemia Reperfusion Injury Market Size by Application
12 International Players Profiles
- 12.1 Angion Biomedica
- 12.1.1 Angion Biomedica Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Ischemia Reperfusion Injury Introduction
- 12.1.4 Angion Biomedica Revenue in Ischemia Reperfusion Injury Business (2014-2019)
- 12.1.5 Angion Biomedica Recent Development
- 12.2 Catalyst Biosciences
- 12.2.1 Catalyst Biosciences Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Ischemia Reperfusion Injury Introduction
- 12.2.4 Catalyst Biosciences Revenue in Ischemia Reperfusion Injury Business (2014-2019)
- 12.2.5 Catalyst Biosciences Recent Development
- 12.3 Ischemix Inc
- 12.3.1 Ischemix Inc Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Ischemia Reperfusion Injury Introduction
- 12.3.4 Ischemix Inc Revenue in Ischemia Reperfusion Injury Business (2014-2019)
- 12.3.5 Ischemix Inc Recent Development
- 12.4 Opsona Therapeutics
- 12.4.1 Opsona Therapeutics Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Ischemia Reperfusion Injury Introduction
- 12.4.4 Opsona Therapeutics Revenue in Ischemia Reperfusion Injury Business (2014-2019)
- 12.4.5 Opsona Therapeutics Recent Development
- 12.5 Pharming
- 12.5.1 Pharming Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Ischemia Reperfusion Injury Introduction
- 12.5.4 Pharming Revenue in Ischemia Reperfusion Injury Business (2014-2019)
- 12.5.5 Pharming Recent Development
- 12.6 TheraSource
- 12.6.1 TheraSource Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Ischemia Reperfusion Injury Introduction
- 12.6.4 TheraSource Revenue in Ischemia Reperfusion Injury Business (2014-2019)
- 12.6.5 TheraSource Recent Development
- 12.7 Bolder Biotechnology
- 12.7.1 Bolder Biotechnology Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Ischemia Reperfusion Injury Introduction
- 12.7.4 Bolder Biotechnology Revenue in Ischemia Reperfusion Injury Business (2014-2019)
- 12.7.5 Bolder Biotechnology Recent Development
- 12.8 Corline Biomedical
- 12.8.1 Corline Biomedical Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Ischemia Reperfusion Injury Introduction
- 12.8.4 Corline Biomedical Revenue in Ischemia Reperfusion Injury Business (2014-2019)
- 12.8.5 Corline Biomedical Recent Development
- 12.9 Mifcortx
- 12.9.1 Mifcortx Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Ischemia Reperfusion Injury Introduction
- 12.9.4 Mifcortx Revenue in Ischemia Reperfusion Injury Business (2014-2019)
- 12.9.5 Mifcortx Recent Development
- 12.10 Balmes Transplantation
- 12.10.1 Balmes Transplantation Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Ischemia Reperfusion Injury Introduction
- 12.10.4 Balmes Transplantation Revenue in Ischemia Reperfusion Injury Business (2014-2019)
- 12.10.5 Balmes Transplantation Recent Development
- 12.11 NovelMed Therapeutics
- 12.12 Hope Pharmaceuticals
- 12.13 Omeros Corp
- 12.14 Prothix
- 12.15 SBI Pharmaceuticals
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Ischemia Reperfusion Injury . Industry analysis & Market Report on Ischemia Reperfusion Injury is a syndicated market report, published as Global Ischemia Reperfusion Injury Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Ischemia Reperfusion Injury market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
